Delivery Order SPE2DB20D3111-SPE2DB24FA9HY

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,292.85 firm fixed price contract is for the supply of the medication Olumiant 2 mg tablet. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,813.16, is for the delivery of Olumiant 4 MG tablets. It is a firm fixed price, delivery order contract with an ultimate completion date of October 25, 2024. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olumiant 4 mg tablets. The contract has a ceiling value of $6,791.68 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, through its Corporate Office division, will deliver the pharmaceutical product to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $3,919.17 award is for the provision of Olumiant 2 mg tablets, a pharmaceutical product, in support of military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with a performance period through December 31, 2025. This IDC serves as the...
This is a delivery order under a federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $18,864.14 firm-fixed-price order is for the prescription medication Olumiant 2 mg tablets. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a DLA Troop Support Medical IDC valued up to $999,999,999 through December 2025 to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,908.02 firm fixed-price delivery order is for the supply of Olumiant 2 mg tablets, a medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order for OLUMIANT 2 MG TABLET 30S, placed with pharmaceutical distributor AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $15,121.71 firm fixed-price contract has a completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a comprehensive vehicle for providing various pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $3,601.87 firm fixed-price delivery order is for the supply of 4565404288 ! OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,272.35 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Olumiant 2 mg tablets. The $13,963.16 firm fixed-price delivery order has a completion date of February 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA9HY
    Delivery Order

This is a $15,313.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Olumiant 2 mg tablets. The contract has a completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of medical commodities, including prescription drugs, medical supplies, and equipment. These IDCs serve as primary vehicles for DLA and other agencies to efficiently procure essential pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other federal healthcare programs. This specific delivery order does not have a set-aside designation.

Generated 12/19/24, 9:35 AM